La vacunación del personal sanitario

Medicina Clinica

Volumn 113, Issue 15, 1999, Pages 583-591

  Campins, Magda ^a   Torres, Miquel ^b   Bayas, José María ^c   Serra, Consol ^d,e   Bruguera, Miquel ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DE L ESPERIT SANT   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d CEPPS Ctro Estud Programas S   (Spain)

^e UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; HEPATITIS B VACCINE; TETANUS TOXOID;

ARTICLE; CHICKENPOX; DRUG SAFETY; HEALTH CARE PERSONNEL; HEPATITIS B; IMMUNIZATION; INFECTION PREVENTION; OCCUPATIONAL EXPOSURE; PREVENTIVE MEDICINE; TETANUS; TREATMENT INDICATION; VACCINATION; HUMAN; INFECTION CONTROL; PREVENTIVE HEALTH SERVICE; REVIEW; VIRUS INFECTION;

HEALTH PERSONNEL; HUMANS; IMMUNIZATION; INFECTION CONTROL; PREVENTIVE HEALTH SERVICES; VIRUS DISEASES;

EID: 0033530489     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Salleras L, Vidal J Bruguera M, Gené J, Batalla J, Bayas JM et al. Vacunaciones del adulto. Med Clin (Barc) 1994; 102 (Supl 1): 42-55.
2. a ed.). Filadelfia: American College of Physicians, 1994.
3. Grupo de Trabajo de Vacunación en el Adulto. Sociedad Española de Higiene y Medicina Preventiva Hospitalaria. Guia de vacunación en el adulto. Madrid: Gráficas Laga, S.L., 1995.
4. a ed.). Barcelona: Doyma Libros S.A., 1994.
5. Generalitat de Catalunya. Departement de Sanitat i Seguretat Social. Llibre Blanc. Bases per a la integració de la prevenció a la práctica assistencial. Barcelona: Doyma S.A., 1993.
6. Desforges JF. Childhood immunizations. N Engl J Med 1992; 327: 1.794-1.800.
7. Desforges JF. Immunization of adults. N Engl J Med 1993; 13: 1.252-1.258.
8. Centers for Disease Control. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 1993; 42: 1-18.
9. Bayas JM, Vilella A, Tural C, Verdaguer J, Nebot X, Prat A et al. Necesidades de vacunación del adulto. Medicina Integral 1995; 25: 72-76.
10. Bayas JM, Carbó JM, Batalla J. Inmunización. Vacunas empleadas en las clínicas de viajeros. Indicaciones, contraindicaciones y protección conferida. JANO 1996; 51: 325-331.
11. Immunization of Health-Care Workers. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997; 46: 1-35.
12. Hadler SC, Doto IL, Maynard JE, Smith J, Clark B, Mosley J et al. Occupational risk of hepatitis B infection in hospital workers. Infection Control 1985; 6: 24-31.
13. Bruguera M. La hepatitis B en el personal sanitario. Med Clin (Barc) 1986; 86: 676-680.
14. Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC. Viral hepatitis in health care personnel at the Johns Hopkins Hospital. Arch Intern Med 1993; 153: 1.705-1.712.
15. Gibas A, Blewett DR, Schoenfled DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol 1992; 136: 603-610.
16. Bruguera M. Epidemiología de la hepatitis B. Med Clin (Barc) 1980; 74: 1-4.
17. Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995; 75: 1.047-1.056.
18. Harris JR, Finger RF, Kobayashi JM, Hadler SC, Murphy BL, Berkelman RL et al. The low risk of hepatitis B in rural hospitals. Results of seroepidemiologic survey. JAMA 1984; 252: 3.270-3.272.
19. The Incident Investigation Team. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997; 336: 178-184.
20. Carl M, Blaquey DL, Francis DP, Maynard JE. Interruption of hepatitis B transmission by modification of a gynaecologist's surgical technique. Lancet 1982; 1: 731-733.
21. Bell DM, Shapiro CN, Culver DH, Martone WJ, Curran JW, Hughes JM. Risk of hepatitis B and human immunodeficiency virus transmission to a patient from an infected surgeon due to percutaneous injury during an invasive procedure: estimates based on a model. Infect Agents Dis 1992; 1: 263-269.
22. Harpaz R, Von Seidlen L, Averhoff FM, Torners MP, Sinha SD, Kotsoponlou K. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996; 334: 549-554.
23. Grupo Espanol de Estudio de la Hepatitis B. Hepatitis B en personal hospitalario: morbilidad, exposición accidental, vacunación y análisis de costes. Med Clin (Barc) 1987, 88: 232-236.
24. Grupo Español para el Estudio de las Hepatitis Víricas. Informe sobre la utilización de la vacuna antihepatitis B en personal sanitario en hospitales españoles. Med Clin (Barc) 1988; 90: 355-357.
25. Louther J, Feldman J, Rivera P, Villa N, DeHovitz J, Sepkowitz KA. Hepatitis B vaccination program at a New York city hospital: seroprevalence, seroconversion and declination. Am J Infect Control 1998; 26: 423-427.
26. Bayas JM, Bruguera M, Vilella A, Bare ML, Prat A, Vidal J et al. Vacunación de estudiantes de medicina y enfermeria trente a la hepatitis B. Med Clin (Barc) 1993; 101: 8-11.
27. Silva AE, McMahon BJ, Parkinson AJ, Sjögren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin Infect Dis 1998; 26: 895-897.
28. Wismans P, Van Haltum J, Stelling T, Poel J, De Gast GC. Effect of supplementary vaccination in healthy non-responders to hepatitits B vaccination. Hepatogastroenterology 1988; 35: 78-79.
29. Geberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995; 332: 444-451.
30. Alimonos K, Nafziger AN, Murray J, Bertino JS. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are implications in terms of cost-effectiveness? Clin Infect Dis 1998; 26: 566-571.
31. Bulkow LR, Wainwright RB, McMahon BJ, Parkinson AJ. Increases in levels of antibody to hepatitis B surface antigen in an immunized population. Clin Infect Dis 1998; 26: 933-937.
32. Hammond GW, Cheang M. Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J 1984; 131: 449-452.
33. Adal KA, Flowers R, Anglim AM, Hayden FG, Titus MG, Coyner BJ et al. Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 1996; 17: 641-648.
34. Pachucki CT, Pappas SA, Fuller GF, Krause SL, Lentino JR, Schaaff DM. Influenza A among hospital personnel and patients: implications for recognition, prevention and control. Arch Intern Med 1989; 149: 77-80.
35. Gomolin IH, Leib HB, Arden NH, Sherman FT. Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management. J Am Geriatr Soc 1995; 43: 71-74.
36. Potter J, Stott DJ, Roberts MA, Elder AG, O'Donell B, Knight PV et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175: 1-6.
37. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47: 1-29.
38. Atkinson WL, Markowitz LE, Adams NC, Seastrom GR. Transmission of measles in medical settings. United States, 1985-1989. Am J Med 1991; 91 (Supl 3B): 320-324.
39. Poland GA, Nichol KL. Medical students as sources of rubella and measles outbreaks. Arch Intern Med 1990; 150: 44-46.
40. Subbarao EK, Amin S, Kumar ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991; 163: 876-878.
41. Bayas JM, Vilella A, Prat A, Salleras LI. Inmunidad al sarampión en adultos jóvenes. Med Prev 1995; 1: 22-25.
42. Mas Pujol M, Fernández E, Díez J. Estudio descriptivo sobre el estado inmunitario frente a la rubéola en las mujeres en edad fértil de una consulta de medicina general. Aten Primaria 1987; 4: 460-463.
43. Campins M, Olona M, Rosselló J, Sala R, Juste C, Penella J et al. Estudio del nivel inmunitario trente a la rubéola en el personal sanitario femenino. Rev Esp Microbiol Clin 1988; 3: 180-182.
44. Advisory Committee on Infectious within Hospitals of the American Hospital Association. Recommendations for the control of rubella within hospitals. Infect Control 1981; 2: 410-411.
45. Polk BF, White JA, DeGirolami PC, Modlin JF. An outbreak of rubella among hospital personnel. N Engl J Med 1980; 303: 541-545.
46. Wharton M, Cochi SL, Hutcheson RH, Schaffner W. Mumps transmission in hospitals. Arch Intern Med 1990; 150: 47-49.
47. Kaplan KM, Marder DC, Cochi SL, Preblud SR. Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA 1988; 260: 1.434-1.438.
48. Eliminació del xarampió a Catalunya per a l'any 2000: bases científiques i programa. Generalitat de Catalunya: Departament de Sanitat i Seguretat Social, 1999.
49. Resolució de 8 de febrer de 1980 d'aprovació del calendari de vacunacions sistemàtiques. Diari Oficial de la Generalitat de Catalunya n.o 47 de 27 de febrer de 1980.
50. Böttiger M, Christenson B, Romanus V, Tarariger J, Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps and rubella. B Med J 1987; 295: 1.264-1.267.
51. Peltola H, Kurki T, Virtanen M, Nissinen M, Karanko V, Hukkanen V et al. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet 1986; 18: 137-139.
52. Resolució de 15 d'abril de 1988 d'aprovació del nou calendari de vacunacions sistemàtiques. Diari Oficial de la Generalitat de Catalunya n.o 983 de 26 d'abril de 1988.
53. Bayas JM, Vilella A, Vidal J, Nebot X, Garbó JM, Navarro G et al. Susceptibilidad al sarampión, rubéola y parotiditis en adultos jóvenes. Med Clin (Barc) 1996; 106: 561-564.
54. Centers for Disease Control and Prevention. Measles, mumps and rubella vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998; 47: 1-59.
55. Nilsson A, Ortqvist A. Severe varicella pneumonia in adults in Stockholm County 1980-1989. Scand J Infect Dis 1996; 28: 121-123.
56. Weber DJ, Rutala WA, Hamilton H. Prevention and control of varicellazoster infections in healthcare facilities. Infect Control Hosp Epidemiol 1996; 17: 694-705.
57. Lyznicki J, Bezman RJ, Genel M. Report of the Council on Scientific Affairs, American Medical Association: immunization of healthcare workers with varicella vaccine. Infect Control Hosp Epidemiol 1998; 19: 348-353.
58. Krasinski K, Holzman RS, LaCouture R, Florman A. Hospital experience with varicella zoster-virus. Infect Control 1986; 7: 312-314.
59. Person MJ, Bell SM, Robertson PW. Determination and importance of varicella immune status of nursing staff in a children's hospital. J Hosp Infect 1990; 15: 347-351.
60. Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993; 83: 1.717-1.720.
61. McKinney WP, Horowitz MM, Battiola RJ. Susceptibility of hospital-ba-sed health care personnel to varicella-zoster virus infections. Am J Infect Control 1989; 17: 26-30.
62. Nettleman MD, Schmid M. Controlling varice la in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers. Infect Control Hosp Epidemiol 1997; 18: 504-508.
63. Centers for Disease Control. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45: 1-36.
64. Gershon AA, LaRussa P, Steinberg S. The varicella vaccine. Clinical trials in immunocompromised individuals. Infect Dis Clin North Am 1996; 3: 583-594.
65. Rosenblum LS, Villarino ME, Nainan OV, Melish ME, Hadler SC, Pinsky PP et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991; 164: 476-482.
66. Mbithi JN, Springthorpe VS, Boulet JR, Sattar SA. Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol 1992; 30; 757-763.
67. Klein BS, Michaels JA, Rytel MW, Berg KG, Davis JP. Nosocomial hepatitis A: a multinursery outbreak in Wisconsin. JAMA 1984; 252: 2.716-2.721.
68. Goodman RA. Nosocomial hepatitis A. Ann Intern Med 1985; 103: 452-454.
69. Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health 1993; 83: 1.979-1.984.
70. Pañella H, Bayas JM, Maldonado R, Caylà JA, Vilella A, Sala C et al. Brote epidémico de hepatitis A relacionado con una guarderia. Gastroenterol Hepatol 1998; 21: 346-351.
71. Van Damme P, Cramm M, Van der Auwera JC, Meheus A. Hepatitis A vaccination for health care workers. Br Med J 1993; 306: 1.615.
72. Vargas V, Buti M, Hernández JM, Jardi R, Portell A, Esteban R et al. Prevalencia de anticuerpos contra el virus de la hepatitis A en la poblacion general. Estudio comparative, 1977-1985. Med Clin (Barc) 1987; 88: 144-146.
73. Salleras L, Bruguera M, Vidai J, Taberner JL, Plans P, Jiménez de Anta MT et al. Cambio del patron epidemiológico de la hepatitis A en Espana. Med Clin (Barc) 1992; 99: 87-89.
74. Buti M, Campins M, Jardi J, Navas E, Cotrina M, Llobet E et al. Seroepidemiologia de la infección por el virus de la hepatitis A en estudiantes de medicina y enfermería. Papel de la vacunación. Gastroenterol Epidemiol 1996; 19: 199-202.
75. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996 45: 1-31.
76. Arrazola P, Campins M, De Juanes JR. Vacunaciones en sanitarios. En: Vacunación en adultos. Sociedad Española de Medicina Preventiva, Salud Pública e Higiene. Boletin 1 (enero-marzo de 1998).
77. Bruguera M, Bayas JM, Vilella A, Tural C, Gonzalez A, Vidal J et al. Immunogenicity and reactogenicity of a combined hepatitis A and hepatitis B vaccine in young adults. Vaccine 1996; 14: 1.407-1.411.
78. Navas E, Bayas JM, Bruguera M, Vidal J, Gali N, Taberner JL et al. Eficiencia de la detección prevacunal de anti-VHA en los programas de vacunación antihepatitis A. Med Clin (Barc) 1995; 105: 168-171.
79. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA et al. Protection against hepatitis A by an inactivated vaccine JAMA 1994; 271: 1.328-1.334.
80. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity and long-term antibody persistence. J Med Virol 1994; 44: 446-451.
81. Cohen MS, Steere AC, Baltimore R, Von Graevenitz A, Pantelick E, Camp B et al. Possible nosocomial transmission of group Y Neisseria meningitidis among oncology patients. Ann Intern Med 1979; 91: 7-12.
82. Rose HD, Lenz IE, Sheth NK. Meningococcal pneumonia: a source of nosocomial infection. Arch Intern Med 1981; 141: 575-577.
83. CDC. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-27.
84. Reingold AL, Broome CV, Hightower AW, Ajello GW, Bolan GA, Adamsbaum C et al. Age specifics differences in duration of clinical protection after vaccination with meningococcal polysaccharyde A vaccine. Lancet 1985; 2: 114-118.
85. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oralpoliovirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-26.
86. a ed.). Baltimore, MD: Williams & Wilkins, 1997; 357-394.
87. Weber DJ, Rutala WA. Pertussis: an underappreciated risk for nosocomial outbreaks, Infec Control Hosp Epidemiol 1998; 19: 825-828.
88. Bayas JM. Vacuna trente a la difteria y el tétanos. En: Campins Martí M, Moraga Llop FA, editores. Vacunas 1998. Barcelona: Prous Science, 1998; 99-108.
89. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-25.
90. a ed.). Baltimore, MD: Williams & Wilkins 1997; 398-435.
91. Weingarten S, Riedinger M, Bolton LB, Miles P, Ault M. Barriers to influenza vaccine acceptance: a survey of physicians and nurses. Am J Infect Control 1989; 17: 202-207.
92. Harbarth S, Siegrist CA, Schira JC, Wunderli W, Pittet D. Influenza immunization: improving compliance of health care workers. Infect Control Hosp Epidemiol 1998; 19: 337-342.
93. Nichol KL, Huge M. Influenza vaccination of health care workers. Infect Control Hosp Epidemiol 1997; 18: 189-194.